Elizabeth Marvin
Dermatology · Lebanon, NHNPI 1427581784
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations.
Across 47 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$186
- Johnson & Johnson$178
- Lilly USA, LLC$128
- Sanofi$80
- Almirall LLC$60
- UCB, Inc.$48
- plus $341 from 10 others
What the payments were for
- Food & beverage$1,020100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $186 |
| Johnson & Johnson | 8 | $178 |
| Lilly USA, LLC | 6 | $128 |
| Sanofi | 3 | $80 |
| Almirall LLC | 2 | $60 |
| UCB, Inc. | 2 | $48 |
| Sun Pharmaceutical Industries Inc. | 2 | $46 |
| Novartis | 2 | $45 |
| Dermavant Sciences, Inc. | 3 | $44 |
| Galderma Laboratories, L.p. | 2 | $42 |
| Amgen | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Journey Medical Corporation | 2 | $33 |
| Organon | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Strata Skin Sciences, Inc. | 1 | $16 |
How this compares
$1,020 in reported general payments places this provider in the 55th percentile of 75 dermatology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 15 | $55,063 |
| Ketoconazole | 161 | $2,791 |
| Clobetasol Propionate | 42 | $1,605 |
| Metronidazole | 23 | $935 |
| Fluocinolone Acetonide | 13 | $780 |
| Fluocinonide | 24 | $743 |
| Triamcinolone Acetonide | 90 | $683 |
| Betamethasone Dipropionate | 11 | $429 |
| Hydrocortisone | 90 | $392 |
| Clindamycin Phosphate | 11 | $317 |
| Mometasone Furoate | 11 | $217 |
| Cefadroxil | 13 | $40 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Lebanon
- Yulianna RussakLebanon$170K
- Michael ChapmanLebanon$39K
- Denise AaronLebanon$8K
- Emily ShaughnessyLebanon$6K
- Nicole PaceLebanon$6K
- Natalie FragosoLebanon$4K
- Brian SimmonsLebanon$3K
- Joi CarterLebanon$135
- Chenin RyanLebanon$87
- Alicia DagrosaLebanon$65
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.